Longevity

Lifespan extension therapy:  Formononetin, isolated from from Astragalus membranaceus (AM), increases life span via up-regulation of its target gene BubR1, 10/November/2017, 8.57 am

Lifespan extension therapy:  Formononetin, isolated from from Astragalus membranaceus (AM), increases life span via up-regulation of its target gene BubR1, 10/November/2017, 8.57 am 960 720 Dr Boomi's Genom-2-Discovery Center

 What they say: Introduction:  A recent study from the Department of Genetics, Paul F. Glenn Laboratories for the Biological Mechanisms of Aging Harvard Medical School, Boston,USA; and Department of Pharmacology, School…

read more

Lifespan extension therapy: Amorfrutin A, isolated from Amorpha fruticosa L,  may increase life span via up-regulation of its target gene BubR1, 8/October/2017, 10.45 pm

Lifespan extension therapy: Amorfrutin A, isolated from Amorpha fruticosa L,  may increase life span via up-regulation of its target gene BubR1, 8/October/2017, 10.45 pm 960 720 Dr Boomi's Genom-2-Discovery Center

 What they say: Introduction:  A recent study from the Department of Genetics, Paul F. Glenn Laboratories for the Biological Mechanisms of Aging Harvard Medical School, Boston,USA; and Department of Pharmacology, School…

read more

Lifespan extension therapy: 5,4′-dihydroxy-7,8-dimethoxyflavanone (DHDMF), found abundantly in Dodonaea viscosa,  may increase life span via up-regulation of its target gene BubR1, 7/November/2017, 9.17 am

Lifespan extension therapy: 5,4′-dihydroxy-7,8-dimethoxyflavanone (DHDMF), found abundantly in Dodonaea viscosa,  may increase life span via up-regulation of its target gene BubR1, 7/November/2017, 9.17 am 960 720 Dr Boomi's Genom-2-Discovery Center

 What they say: Introduction:  A recent study from the Department of Genetics, Paul F. Glenn Laboratories for the Biological Mechanisms of Aging Harvard Medical School, Boston,USA; and Department of Pharmacology, School…

read more

Lifespan extension therapy: : Wogonin, isolated from Scutellaria radix,  may increase life span via up-regulation of its target gene BubR1, 5/November/2017,11.14 pm

Lifespan extension therapy: : Wogonin, isolated from Scutellaria radix,  may increase life span via up-regulation of its target gene BubR1, 5/November/2017,11.14 pm 960 720 Dr Boomi's Genom-2-Discovery Center

 What they say: Introduction:  A recent study from the Department of Genetics, Paul F. Glenn Laboratories for the Biological Mechanisms of Aging Harvard Medical School, Boston,USA; and Department of Pharmacology, School…

read more

Natural product-derived Life-extension therapy: Andrographolide, isolated from the stem and leaves of Andrographis paniculata, inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span, 5/November/2017, 11.00 pm

Natural product-derived Life-extension therapy: Andrographolide, isolated from the stem and leaves of Andrographis paniculata, inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span, 5/November/2017, 11.00 pm 960 720 Dr Boomi's Genom-2-Discovery Center

What they say: A study from the Institute of Healthy Ageing, Centre for Diabetes and Endocrinology, Department of Medicine, University College London, London WC1E 6JJ, UK shows that “Ribosomal protein S6 kinase 1…

read more

Natural product-based combinatorial therapy for ageing-associated diseases and Lifespan extension: A therapeutic mix encompassing Glycyrrhetinic acid, Ginsenoside and 4-Bromoflavone (GGB) increases NMN/NAD levels, decreases interaction of DBC1 with PARP1, increases PARP1 activity, promotes DNA repair, augments tolerance against radiation, cancer and aging via down regulation of its target gene, 4/November/2017, 11.51 pm

Natural product-based combinatorial therapy for ageing-associated diseases and Lifespan extension: A therapeutic mix encompassing Glycyrrhetinic acid, Ginsenoside and 4-Bromoflavone (GGB) increases NMN/NAD levels, decreases interaction of DBC1 with PARP1, increases PARP1 activity, promotes DNA repair, augments tolerance against radiation, cancer and aging via down regulation of its target gene, 4/November/2017, 11.51 pm 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say A study from Department of Genetics, Paul F. Glenn Center for the Biology of Aging, Harvard Medical School, Boston, MA, USA; and Department of Pharmacology, School…

read more